All Stories

  1. Comparative analysis of EEG in patients with schizophrenia receiving various atypical antipsychotics

    Article • Bulletin of Siberian Medicine, April 2024, Siberian State Medical University

    Svetlana A Ivanova

  2. Ассоциативный анализ гаплотипов и регуляторный потенциал генов серотониновых рецепторов у больных шизофренией с тардивной дискинезией

    Article • Сибирский вестник психиатрии и наркологии, March 2024, Mental Health Research Institute

    Svetlana A Ivanova

  3. NOS1AP Gene Variants and Their Role in Metabolic Syndrome: A Study of Patients with Schizophrenia

    Article • Biomedicines, March 2024, MDPI AG

    Svetlana A Ivanova

  4. Untargeted Plasma Metabolomic Profiling in Patients with Depressive Disorders: A Preliminary Study

    Article • Metabolites, February 2024, MDPI AG

    Svetlana A Ivanova

  5. Associations between components of metabolic syndrome and cognitive impairment in patients with schizophrenia

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2024, Media Sphere Publishing Group

    Svetlana A Ivanova

  6. Associations of serum neuromarkers with clinical features of Parkinson’s disease

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2024, Media Sphere Publishing Group

    Svetlana A Ivanova

  7. Serum neurofilament light chains in assessing the course of multiple sclerosis

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2024, Media Sphere Publishing Group

    Svetlana A Ivanova

  8. The relationship between the rs6265 polymorphism of the BDNF gene and the level of serum neurotrophic factor in patients with Parkinson’s disease

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2024, Media Sphere Publishing Group

    Svetlana A Ivanova

  9. Serum neurofilaments light chain as a diagnostic marker of multiple sclerosis

    Article • Russian neurological Journal, November 2023, Medical Informational Agency Publishers

    Svetlana A Ivanova

  10. Differential Expression of Proteins Associated with Bipolar Disorder as Identified Using the PeptideShaker Software

    Article • International Journal of Molecular Sciences, October 2023, MDPI AG

    Svetlana A Ivanova

  11. Relationship of Neurospecific Serum Proteins with Clinical Features in Depressive Episode and Recurrent Depressive Disorder

    Article • Psikhiatriya, September 2023, Medical Informational Agency Publishers

    Svetlana A Ivanova

  12. Serum Levels of S100B Protein and Myelin Basic Protein as a Potential Biomarkers of Recurrent Depressive Disorders

    Article • Journal of Personalized Medicine, September 2023, MDPI AG

    Svetlana A Ivanova

  13. Association of Single Nucleotide Polymorphisms of Cytokine Genes with Depression, Schizophrenia and Bipolar Disorder

    Article • Genes, July 2023, MDPI AG

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  14. Building Predictive Models for Schizophrenia Diagnosis with Peripheral Inflammatory Biomarkers

    Article • Biomedicines, July 2023, MDPI AG

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  15. EEG Frontal Asymmetry in Unipolar and Bipolar Depression

    Article • Psikhiatriya, June 2023, Medical Informational Agency Publishers

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  16. Association of Peripheral Inflammatory Biomarkers and Growth Factors Levels with Sex, Therapy and Other Clinical Factors in Schizophrenia and Patient Stratification Based on These Data

    Article • Brain Sciences, May 2023, MDPI AG

    Svetlana A Ivanova

  17. Роль полиморфизма генов дофаминовой и глутаматной систем в клинической гетерогенности шизофрении и развитии антипсихотик-индуцированных побочных эффектов

    Article • Сибирский вестник психиатрии и наркологии, April 2023, Mental Health Research Institute

    Svetlana A Ivanova

  18. The Influence of Antipsychotic Treatment on the Activity of Abzymes Targeting Myelin and Levels of Inflammation Markers in Patients with Schizophrenia

    Article • Biomedicines, April 2023, MDPI AG

    Svetlana A Ivanova

  19. Serum Growth Factors in Schizophrenia Patients

    Article • Current Issues in Molecular Biology, April 2023, MDPI AG

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  20. In vitro effect of serum IgGs with oxidoreductase activities of schizophrenic patients on apoptosis level

    Article • Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery), March 2023, PANORAMA Publishing House

    Svetlana A Ivanova

  21. Cell Adhesion Molecules in Schizophrenia Patients with Metabolic Syndrome

    Article • Metabolites, March 2023, MDPI AG

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  22. The Role of Glutamatergic Gene Polymorphisms in the Clinical Phenotypes of Schizophrenia

    Article • Genes, February 2023, MDPI AG

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  23. Chemokine Dysregulation and Neuroinflammation in Schizophrenia: A Systematic Review

    Article • International Journal of Molecular Sciences, January 2023, MDPI AG

    Svetlana A Ivanova

  24. Coherence of the electroencephalogram and peripheral markers of nerve tissue damage in depressive disorders

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2023, Media Sphere Publishing Group

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  25. BDNF gene RS6265 polymorphism in patients with multiple sclerosis of Tomsk region

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2023, Media Sphere Publishing Group

    Svetlana A Ivanova

  26. Cytokines as Potential Biomarkers of Clinical Characteristics of Schizophrenia

    Article • Life, November 2022, MDPI AG

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  27. Multiplex Analysis of Serum Cytokine Profiles in Systemic Lupus Erythematosus and Multiple Sclerosis

    Article • International Journal of Molecular Sciences, November 2022, MDPI AG

    Svetlana A Ivanova

  28. Executive dysfunction in affective disorders: differences in bipolar affective disorder and depressive episode

    Article • Bulletin of Siberian Medicine, October 2022, Siberian State Medical University

    Svetlana A Ivanova

  29. Metabolic Hormones in Schizophrenia Patients with Antipsychotic-Induced Metabolic Syndrome

    Article • Journal of Personalized Medicine, October 2022, MDPI AG

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  30. Levels of Acylcarnitines and Branched-Chain Amino Acids in Antipsychotic-Treated Patients with Paranoid Schizophrenia with Metabolic Syndrome

    Article • Metabolites, September 2022, MDPI AG

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  31. Immunoglobulins G of Patients with Schizophrenia Protects from Superoxide: Pilot Results

    Article • Journal of Personalized Medicine, September 2022, MDPI AG

    Svetlana A Ivanova

  32. Cytokine level in patients with mood disorder, alcohol use disorder and their comorbidity

    Article • The World Journal of Biological Psychiatry, July 2022, Taylor & Francis

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  33. The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia

    Article • Genes, July 2022, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  34. Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein

    Article • International Journal of Molecular Sciences, July 2022, MDPI AG

    Svetlana A Ivanova

  35. Serum Cytokine Levels of Systemic Lupus Erythematosus Patients in the Presence of Concomitant Cardiovascular Diseases

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, July 2022, Bentham Science Publishers

    Svetlana A Ivanova

  36. Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia

    Article • Diagnostics, June 2022, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  37. Circuits regulating pleasure and happiness – focus on potential biomarkers for circuitry including the habenuloid complex

    Article • Acta Neuropsychiatrica, May 2022, Cambridge University Press

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  38. Gene Polymorphisms of Hormonal Regulators of Metabolism in Patients with Schizophrenia with Metabolic Syndrome

    Article • Genes, May 2022, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  39. Возможные нейрофизиологические маркеры для дифференциальной диагностики биполярных и униполярных аффективных расстройств

    Article • Сибирский вестник психиатрии и наркологии, January 2022, Mental Health Research Institute

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  40. Оценка цитотоксических эффектов IgG, выделенных из сыворотки крови больных шизофренией

    Article • Сибирский вестник психиатрии и наркологии, January 2022, Mental Health Research Institute

    Svetlana A Ivanova

  41. Molecular genetic study of clinical and cognitive features of schizophrenia: No associations with genes SOD2, GSTO1, NQO1

    Article • Siberian Journal of Clinical and Experimental Medicine, January 2022, Cardiology Research Institute

    Svetlana A Ivanova

  42. Anhedonia as target symptom in personalized therapy of patients with mood disorders and alcohol use disorder comorbidity

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2022, Media Sphere Publishing Group

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  43. Current methods for predicting therapeutic response in patients with depressive disorders

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2022, Media Sphere Publishing Group

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  44. Correlations between clinical features of bipolar affective disorder and serum concentrations of ANKRD12 gene product, coagulation factor XIII, and cadherin 5

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2022, Media Sphere Publishing Group

    Svetlana A Ivanova

  45. Metabolic Syndrome in a Population of In-Patients with Schizophrenia in the Western Siberia

    Article • Psikhiatriya, December 2021, Medical Informational Agency Publishers

    Svetlana A Ivanova

  46. A New Paradigm to Indicate Antidepressant Treatments

    Article • Pharmaceuticals, December 2021, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  47. Beta-Endorphin and Oxytocin in Patients with Alcohol Use Disorder and Comorbid Depression

    Article • Journal of Clinical Medicine, December 2021, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  48. Assessment of serum BDNF levels in complex rehabilitation of patients with ischemic stroke using traditional approaches to the restoration of motor functions

    Article • Bulletin of Siberian Medicine, October 2021, Siberian State Medical University

    Svetlana A Ivanova

  49. Association of PIP4K2A Polymorphisms with Alcohol Use Disorder

    Article • Genes, October 2021, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  50. Влияние органических солей лития на содержание белков Akt/mTOR-сигнального пути в мононуклеарах периферической крови больных биполярным аффективным расстройством

    Article • Сибирский вестник психиатрии и наркологии, October 2021, Mental Health Research Institute

    Svetlana A Ivanova

  51. Study of Early Onset Schizophrenia: Associations of GRIN2A and GRIN2B Polymorphisms

    Article • Life, September 2021, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  52. Clinical Evaluation of Different Treatment Strategies for Motor Recovery in Poststroke Rehabilitation during the First 90 Days

    Article • Journal of Clinical Medicine, August 2021, MDPI AG

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  53. Preliminary Pharmacogenetic Study to Explore Putative Dopaminergic Mechanisms of Antidepressant Action

    Article • Journal of Personalized Medicine, July 2021, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  54. Global hypomyelination of the brain white and gray matter in schizophrenia: quantitative imaging using macromolecular proton fraction

    Article • Translational Psychiatry, June 2021, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  55. Electroencephalographic Markers of Depressive Disorders Resistance to Pharmacotherapy and Determination of a Possible Approach to Individual Prognosis of Therapy Effectiveness

    Article • Psikhiatriya, June 2021, Medical Informational Agency Publishers

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  56. Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics

    Article • Pharmaceuticals, May 2021, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  57. Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia

    Article • Journal of Personalized Medicine, March 2021, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  58. Features of brain activity in alcohol dependence in the task of inhibitory control

    Article • Bulletin of Siberian Medicine, January 2021, Siberian State Medical University

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  59. Amino Acid and Acylcarnitine Levels in Chronic Patients with Schizophrenia: A Preliminary Study

    Article • Metabolites, January 2021, MDPI AG

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  60. Cognitive impairment in patients after COVID-19

    Article • Yakut Medical Journal, January 2021, Yakutsk Scientific Center for Complex Medical Problems

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  61. Влияние когнитивных функций на уровень суицидального риска у больных шизофренией

    Article • Суицидология, December 2020, LLC M-Center

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  62. Using the quantitative EEG method in predicting the response to treatment of affective disorders

    Article • V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY, December 2020, V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  63. Adipocytokines and Metabolic Syndrome in Patients with Schizophrenia

    Article • Metabolites, October 2020, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  64. Модель прогнозирования метаболического синдрома у больных параноидной шизофренией

    Article • Сибирский вестник психиатрии и наркологии, September 2020, Mental Health Research Institute

    Svetlana A Ivanova

  65. Cognitive Changes in Comorbidity Alcohol Dependence and Affective Disorders

    Article • Psikhiatriya, September 2020, Medical Informational Agency Publishers

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  66. Glutamate Level’s in Blood Serum of Patients with Schisophrenic Spectrum and Bipolar Affective Disorder

    Article • Psikhiatriya, September 2020, Medical Informational Agency Publishers

    Svetlana A Ivanova

  67. Body Fat Parameters, Glucose and Lipid Profiles, and Thyroid Hormone Levels in Schizophrenia Patients with or without Metabolic Syndrome

    Article • Diagnostics, September 2020, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova, Dr Olga Lobacheva

  68. Serum BDNF’s Role as a Biomarker for Motor Training in the Context of AR-Based Rehabilitation after Ischemic Stroke

    Article • Brain Sciences, September 2020, MDPI AG

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  69. Igg-Dependent Hydrolysis of Myelin Basic Protein of Patients with Different Courses of Schizophrenia

    Article • Journal of Immunology Research, August 2020, Hindawi Publishing Corporation

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  70. Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia

    Article • Human Psychopharmacology Clinical and Experimental, May 2020, Wiley

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  71. Cortisol and DHEAS Related to Metabolic Syndrome in Patients with Schizophrenia

    Article • April 2020, Taylor & Francis

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  72. Therapeutic Drug Monitoring of Olanzapine and Cytochrome P450 Genotyping in Nonsmoking Subjects

    Article • Therapeutic Drug Monitoring, April 2020, Wolters Kluwer Health

    Svetlana A Ivanova

  73. Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients

    Article • Frontiers in Psychiatry, February 2020, Frontiers

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  74. IgG-Dependent Dismutation of Superoxide in Patients with Different Types of Multiple Sclerosis and Healthy Subjects

    Article • Oxidative Medicine and Cellular Longevity, February 2020, Hindawi Publishing Corporation

    Svetlana A Ivanova

  75. Amino acids and acylcarnitines as potential metabolomic markers of schizophrenia: new approaches to diagnostics and therapy

    Article • Bulletin of Siberian Medicine, January 2020, Siberian State Medical University

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  76. Clinical and laboratory assessment of the effectiveness of early rehabilitation of patients with stroke using assistive robotic tools

    Article • Bulletin of Siberian Medicine, January 2020, Siberian State Medical University

    Svetlana A Ivanova

  77. Relationship of cognitive disorders with clinical features of alcohol dependence

    Article • Yakut Medical Journal, January 2020, Yakutsk Scientific Center for Complex Medical Problems

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  78. Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression

    Article • Frontiers in Pharmacology, December 2019, Frontiers

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  79. Investigating the potential role of BDNF and PRL genotypes on antidepressant response in depression patients: A prospective inception cohort study in treatment-free patients

    Article • Journal of Affective Disorders, December 2019, Elsevier

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  80. Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome

    Article • Frontiers in Psychiatry, November 2019, Frontiers

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  81. Putative role of pharmacogenetics to elucidate the mechanism of tardive dyskinesia in schizophrenia

    Article • Pharmacogenomics, November 2019, Future Medicine

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  82. Sexual differences in the clinical features of antipsychotic-induced hyperprolactinemia in patients with schizophrenia

    Article • Bulletin of Siberian Medicine, October 2019, Siberian State Medical University

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  83. Суицидальное поведение больных шизофренией с метаболическим синдромом

    Article • Суицидология, August 2019, LLC M-Center

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  84. Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia

    Article • Heliyon, July 2019, Elsevier

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  85. The difference in serum proteomes in schizophrenia and bipolar disorder

    Article • BMC Genomics, July 2019, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  86. Association of Polymorphic Variants of Brain-Derived Neurotrophic Factor Gene (Bdnf Rs6265) and Glutamate Transporter Gene of the Second Type (Slc1a2 Rs4354668) with the Course of Multiple Sclerosis in Patients Living in Tomsk Region

    Article • Annals of the Russian academy of medical sciences, April 2019, Paediatrician Publishers LLC

    Svetlana A Ivanova

  87. A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia

    Article • BMC Medical Genetics, April 2019, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  88. Consider Role of Glutamatergic Habenula-projecting Globus Pallidus in OCD

    Article • Pharmacopsychiatry, February 2019, Thieme Publishing Group

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  89. Opening up new horizons for psychiatric genetics in the Russian Federation: moving toward a national consortium

    Article • Molecular Psychiatry, January 2019, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  90. Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors

    Article • The World Journal of Biological Psychiatry, January 2019, Taylor & Francis

    Svetlana A Ivanova, Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan

  91. SIRT1 Allele Frequencies in Depressed Patients of European Descent in Russia

    Article • Frontiers in Genetics, January 2019, Frontiers

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  92. Disorders of spatial working memory in affective disorders with mild current depression and their neurophysiological correlates

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2019, Media Sphere Publishing Group

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  93. No evidence so far of a major role of AKT1 and GSK3B in the pathogenesis of antipsychotic-induced tardive dyskinesia

    Article • Human Psychopharmacology Clinical and Experimental, January 2019, Wiley

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  94. Brain pathology in schizophrenia: association with clinical and constitutional factors

    Article • Yakut Medical Journal, January 2019, Yakutsk Scientific Center for Complex Medical Problems

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  95. NEUROPHYSIOLOGICAL FEATURES OF PATIENTS WITH DIFFERENT RATES OF ALCOHOL DEPENDENCE DEVELOPMENT

    Article • Вопросы наркологии, January 2019, Journal of Addiction Problems, V. Serbsky NMRCPN

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  96. Stress hormones in men whose professional activities are either office-based or of an extreme emergency nature

    Article • Yakut Medical Journal, January 2019, Yakutsk Scientific Center for Complex Medical Problems

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  97. Morphophenotypic predictor of the development of visceral obesity in patients with schizophrenia receiving antipsychotic therapy

    Article • Bulletin of Siberian Medicine, December 2018, Siberian State Medical University

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  98. Суицидальное поведение больных биполярным аффективным расстройством при коморбидных психических заболеваниях

    Article • Суицидология, November 2018, LLC M-Center

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  99. The evolutionary old forebrain as site of action to develop new psychotropic drugs

    Article • Journal of Psychopharmacology, September 2018, SAGE Publications

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  100. IgG antibodies from the sera of patients degrade myelin basic protein

    Article • Journal of Molecular Recognition, August 2018, Wiley

    Evgeny Ermakov, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  101. Polymorphisms of Catechol-O-Methyl Transferase (COMT) Gene in Vulnerability to Levodopa-Induced Dyskinesia

    Article • Journal of Pharmacy & Pharmaceutical Sciences, August 2018, University of Alberta Libraries

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  102. Remaining Need for In Vitro Test to Elucidate 5-Hydroxytryptamine 2C Receptor Functioning

    Article • Journal of Clinical Psychopharmacology, August 2018, Wolters Kluwer Health

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  103. The functional variant rs334558 of GSK3B is associated with remission in patients with depressive disorders

    Article • Pharmacogenomics and Personalized Medicine, July 2018, Dove Medical Press

    Prof. dr. Anton J Loonen, Svetlana A Ivanova, Anastasia Levchenko, Prof Nikolay A. Bokhan

  104. Parkinson's disease and polymorphisms of the glutamatergic system genes GRIN2A, SLC1A2, and GRIK4

    Article • Neurology neuropsychiatry Psychosomatics, June 2018, IMA Press, LLC

    Svetlana A Ivanova

  105. Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and metabolic syndrome in healthy subjects and schizophrenia patients

    Article • International Journal of Obesity, June 2018, Springer Science + Business Media

    Svetlana A Ivanova

  106. Blood-Derived RNA- and microRNA-Hydrolyzing IgG Antibodies in Schizophrenia Patients

    Article • Biochemistry (Moscow), May 2018, Pleiades Publishing Ltd

    Evgeny Ermakov, Svetlana A Ivanova

  107. Hydrolysis by catalytic IgGs of microRNA specific for patients with schizophrenia

    Article • IUBMB Life, January 2018, Wiley

    Evgeny Ermakov, Svetlana A Ivanova

  108. Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Clozapine

    Article • The Journal of Clinical Psychiatry, December 2017, Physicians Postgraduate Press, Inc

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  109. Commentary on “A non-reward attractor theory of depression”: A proposal to include the habenula connection

    Article • Neuroscience & Biobehavioral Reviews, December 2017, Elsevier

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  110. How brain mechanism of feeling pleasure and happiness evolved during the last 560 million years.

    Article • CNS Spectrums, November 2017, Cambridge University Press

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  111. Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia

    Article • PLoS ONE, September 2017, PLOS

    Evgeny Ermakov, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  112. The role of the habenula in the transition from reward to misery in substance use and mood disorders

    Article • Neuroscience & Biobehavioral Reviews, September 2017, Elsevier

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  113. Circuits regulating pleasure and happiness: evolution and role in mental disorders

    Article • Acta Neuropsychiatrica, May 2017, Cambridge University Press

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  114. Neurohumoral markers that predict the efficiency of pharmacologic therapy of depressive disorders

    Article • Neurochemical Journal, April 2017, Pleiades Publishing Ltd

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  115. Prolactin gene polymorphism (− 1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics

    Article • Schizophrenia Research, April 2017, Elsevier

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  116. Association of Polymorphisms of Serotonin Transporter (5HTTLPR) and 5-HT2C Receptor Genes with Criminal Behavior in Russian Criminal Offenders

    Article • Neuropsychobiology, January 2017, Karger Publishers

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  117. Association of polymorphic variants of PIP5K2A and HTR2C genes with response to antidepressant therapy of patients with a current depressive episode

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2017, Media Sphere Publishing Group

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  118. Association study of genetic markers of schizophrenia and its cognitive endophenotypes

    Article • Russian Journal of Genetics, January 2017, Pleiades Publishing Ltd

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  119. Indices of the antioxidant system and dopamine in blood plasma in the dynamics of microwave resonance therapy in patients with alcoholism

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2017, Media Sphere Publishing Group

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  120. Circuits Regulating Pleasure and Happiness in Bipolar Disorder

    Article • Frontiers in Neural Circuits, January 2017, Frontiers

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  121. Circuits Regulating Pleasure and Happiness in Schizophrenia: The Neurobiological Mechanism of Delusions

    Article • December 2016, IntechOpen

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  122. Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations

    Article • SAGE Open Medicine, November 2016, SAGE Publications

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  123. Circuits Regulating Pleasure and Happiness: The Evolution of the Amygdalar-Hippocampal-Habenular Connectivity in Vertebrates

    Article • Frontiers in Neuroscience, November 2016, Frontiers

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  124. Circuits Regulating Pleasure and Happiness—Mechanisms of Depression

    Article • Frontiers in Human Neuroscience, November 2016, Frontiers

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  125. Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia

    Article • The World Journal of Biological Psychiatry, September 2016, Taylor & Francis

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  126. Circuits Regulating Pleasure and Happiness: A Focus on Addiction, Beyond the Ventral Striatum

    Article • July 2016, IntechOpen

    Svetlana A Ivanova

  127. CYP1A2 and CYP2D6 Gene Polymorphisms in Schizophrenic Patients with Neuroleptic Drug-Induced Side Effects

    Article • Bulletin of Experimental Biology and Medicine, March 2016, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  128. Circuits regulating pleasure and happiness in major depression

    Article • Medical Hypotheses, February 2016, Elsevier

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  129. Antioxidant and Immunotropic Properties of some Lithium Salts

    Article • Journal of Applied Pharmaceutical Science, January 2016, Journal of Applied Pharmaceutical Science

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  130. Use of Carnosine for Oxidative Stress Reduction in Different Pathologies

    Article • Oxidative Medicine and Cellular Longevity, January 2016, Hindawi Publishing Corporation

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  131. Antibodies to native and denatured DNA in the serum of patients with schizophrenia depending on the clinical features of the disease

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2016, Media Sphere Publishing Group

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  132. The association of the DRD3 gene with Parkinson’s disease

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2016, Media Sphere Publishing Group

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  133. Levodopa-Induced Dyskinesia Is Related to Indirect Pathway Medium Spiny Neuron Excitotoxicity: A Hypothesis Based on an Unexpected Finding

    Article • Parkinson s Disease, January 2016, Hindawi Publishing Corporation

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  134. An association of AKT1 gene polymorphism with antidepressant treatment response

    Article • The World Journal of Biological Psychiatry, December 2015, Informa Healthcare

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  135. Serum Glutathione in Patients with Schizophrenia in Dynamics of Antipsychotic Therapy

    Article • Bulletin of Experimental Biology and Medicine, December 2015, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  136. Circuits regulating pleasure and happiness: the evolution of reward-seeking and misery-fleeing behavioral mechanisms in vertebrates

    Article • Frontiers in Neuroscience, October 2015, Frontiers

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  137. DNA-hydrolysing activity of IgG antibodies from the sera of patients with schizophrenia

    Article • Open Biology, September 2015, Royal Society Publishing

    Prof Nikolay A. Bokhan, Evgeny Ermakov, Svetlana A Ivanova

  138. Characteristics of membrane-bound pool of leukocyte lactate dehydrogenase in healthy men of different age

    Article • Human Physiology, July 2015, Pleiades Publishing Ltd

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  139. Serum Levels of Neurosteroids in Patients with Affective Disorders

    Article • Bulletin of Experimental Biology and Medicine, March 2015, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  140. Cytochrome P450 1A2 co-determines neuroleptic load and may diminish tardive dyskinesia by increased inducibility

    Article • The World Journal of Biological Psychiatry, January 2015, Taylor & Francis

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  141. Association Study Indicates a Protective Role of Phosphatidylinositol-4-Phosphate-5-Kinase against Tardive Dyskinesia

    Article • The International Journal of Neuropsychopharmacology, December 2014, Oxford University Press (OUP)

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  142. Proteins of the Akt1/GSK-3β signaling pathway in peripheral blood mononuclear cells of patients with affective disorders

    Article • Neurochemical Journal, July 2014, Pleiades Publishing Ltd

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  143. Dehydroepiandrosterone sulphate as a putative protective factor against tardive dyskinesia

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, April 2014, Elsevier

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  144. Glutamate Concentration in the Serum of Patients with Schizophrenia

    Article • Procedia Chemistry, January 2014, Elsevier

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  145. Glucose-6-phosphate dehydrogenase and catalase activities in erythrocytes of schizophrenic patients under pharmacotherapy with traditional antipsychotics

    Article • Neurochemical Journal, January 2014, Pleiades Publishing Ltd

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  146. Effects of Neuroprotector Cortexin on the Dynamics of Neuroendocrine System Parameters in Patients with Organic Emotionally Labile (Asthenic) Disorders

    Article • Bulletin of Experimental Biology and Medicine, May 2013, Springer Science + Business Media

    Svetlana A Ivanova

  147. New insights into the mechanism of drug-induced dyskinesia

    Article • CNS Spectrums, December 2012, Cambridge University Press

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  148. Conformational Stability of Leukocyte Lactate Dehydrogenase in Healthy Men of Different Age

    Article • Bulletin of Experimental Biology and Medicine, November 2012, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  149. Neurosteroids Dehydroepiandrosterone and Its Sulfate in Individuals with Personality Disorders Convicted of Serious Violent Crimes

    Article • Bulletin of Experimental Biology and Medicine, November 2012, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  150. Effects of dehydroepiandrosterone sulfate on induced apoptosis of lymphocytes in healthy persons

    Article • Human Physiology, September 2012, Pleiades Publishing Ltd

    Svetlana A Ivanova

  151. Study of the indices of antioxidant defense in mental maladaptation

    Article • Human Physiology, September 2012, Pleiades Publishing Ltd

    Svetlana A Ivanova

  152. No involvement of the adenosine A2A receptor in tardive dyskinesia in Russian psychiatric inpatients from Siberia

    Article • Human Psychopharmacology Clinical and Experimental, May 2012, Wiley

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  153. NMDA receptor genotypes associated with the vulnerability to develop dyskinesia

    Article • Translational Psychiatry, January 2012, Springer Science + Business Media

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  154. The correlation between schizophrenia duration and the serum concentration of dehydroepiandrosterone sulfate

    Article • Neurochemical Journal, December 2011, Pleiades Publishing Ltd

    Svetlana A Ivanova

  155. The state of the antioxidant system during therapy of patients with multiple sclerosis

    Article • Biochemistry (Moscow) Supplement Series B Biomedical Chemistry, March 2011, Pleiades Publishing Ltd

    Svetlana A Ivanova

  156. Spontaneous and In Vitro Induced Apoptosis of Lymphocytes and Neutrophils in Patients with Alcohol Dependence

    Article • Bulletin of Experimental Biology and Medicine, July 2010, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  157. Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia

    Article • Human Psychopharmacology Clinical and Experimental, January 2010, Wiley

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  158. PIP5K2A-dependent regulation of excitatory amino acid transporter EAAT3

    Article • Psychopharmacology, July 2009, Springer Science + Business Media

    Undine Lang, Svetlana A Ivanova

  159. Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, April 2009, Elsevier

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  160. P.3.c.044 Tardive dyskinesia and polymorphism of dopamine D3, serotonin 2A and 2C receptors in Russian psychiatric inpatients

    Article • European Neuropsychopharmacology, August 2008, Elsevier

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  161. P.3.d.010 Catabolic-anabolic balance and leucocytes's apoptosis in patients with schizophrenia

    Article • European Neuropsychopharmacology, August 2008, Elsevier

    Svetlana A Ivanova

  162. P.2.b.011 Antidepressant therapy and apoptosis of immnocompetent cells in patients with depressive disorders

    Article • European Neuropsychopharmacology, October 2007, Elsevier

    Svetlana A Ivanova

  163. P.3.c.017 Influence of atypical neuroleptic quetiapine on the serum dehydroepiandrosterone/ cortisol ratio in schizophrenia

    Article • European Neuropsychopharmacology, October 2007, Elsevier

    Svetlana A Ivanova

  164. Signs of apoptosis of immunocompetent cells in patients with depression

    Article • Neuroscience and Behavioral Physiology, June 2007, Springer Science + Business Media

    Svetlana A Ivanova

  165. P.6.063 Clinical and biological effectiveness of anar therapy in opiate addicts

    Article • European Neuropsychopharmacology, January 2005, Elsevier

    Professor Tamara P. Vetlugina, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  166. P.1.045 Psychotropic drugs and homeostatic systems: Mechanism of psychoneuroimmunomodulation

    Article • European Neuropsychopharmacology, January 2005, Elsevier

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  167. P.2.016 Influence of atypical neuroleptic on cell apoptosis in patients with schizophrenia in the course of the therapy

    Article • European Neuropsychopharmacology, January 2005, Elsevier

    Dr Olga Lobacheva, Svetlana A Ivanova

  168. P.1.107 Influence of pharmacotherapy on fas-receptorsand spontaneous apoptosis of lymphocytes in patients with depressive disorders

    Article • European Neuropsychopharmacology, October 2004, Elsevier

    Professor Tamara P. Vetlugina, Svetlana A Ivanova

  169. Immunity system in alcoholism

    Article • Alcoholism Clinical and Experimental Research, August 2004, Wiley

    Professor Tamara P. Vetlugina, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  170. Article • Bulletin of Experimental Biology and Medicine, January 2003, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  171. Article • Bulletin of Experimental Biology and Medicine, January 2003, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova